Treatment of renal hypertension in children by captopril

Area of Science:

• Pediatric Nephrology
• Cardiovascular Pharmacology

Background:

• Renal hypertension in children presents a significant clinical challenge.
• Effective antihypertensive agents are crucial for managing pediatric renal disease.

Purpose of the Study:

• To evaluate the efficacy and safety of captopril in treating renal hypertension in pediatric patients.
• To determine the effectiveness of captopril across different spectrums of renal function.

Main Methods:

• A cohort of nine children (aged 2 months to 13 years) with renal hypertension received captopril treatment.
• Treatment duration ranged from 1.5 to 14 months, with maintenance doses of 1-5 mg/kg/day.
• Patient outcomes were assessed based on renal function status.

Main Results:

• Captopril demonstrated good therapeutic effects in children with normal renal function.
• Positive outcomes were also observed in children with mild renal insufficiency.
• Captopril proved ineffective in patients with end-stage renal disease when dialysis failed to manage fluid balance.

Conclusions:

• Captopril is an effective treatment for renal hypertension in pediatric patients with preserved or mildly compromised renal function.
• Captopril's efficacy is limited in end-stage renal disease patients with fluid management issues.
• Further research may explore alternative therapies for this specific patient group.